Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Revenue (2018 - 2025)

Exagen's Revenue history spans 8 years, with the latest figure at $16.6 million for Q4 2025.

  • For Q4 2025, Revenue rose 21.79% year-over-year to $16.6 million; the TTM value through Dec 2025 reached $66.6 million, up 19.65%, while the annual FY2025 figure was $66.6 million, 19.65% up from the prior year.
  • Revenue reached $16.6 million in Q4 2025 per XGN's latest filing, down from $17.2 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $17.2 million in Q3 2025 to a low of $7.6 million in Q2 2022.
  • Average Revenue over 5 years is $13.4 million, with a median of $13.5 million recorded in 2023.
  • Peak YoY movement for Revenue: tumbled 40.45% in 2022, then skyrocketed 85.87% in 2023.
  • A 5-year view of Revenue shows it stood at $12.7 million in 2021, then increased by 1.17% to $12.8 million in 2022, then rose by 7.23% to $13.8 million in 2023, then dropped by 0.8% to $13.7 million in 2024, then rose by 21.79% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Revenue are $16.6 million (Q4 2025), $17.2 million (Q3 2025), and $17.2 million (Q2 2025).